Features
Get A Demo
Plans
Sign Up
Login
All Federal Contract IDV Awards
Help
Federal Supply Schedule V797D70052
Award Date
2/1/17
Last Date to Order
3/31/24
Overview
🤔 AI Insights
Buyer Personas
1
Industry Personas
Buyer Personas In this Market
70
Activity
Contract IDVs
3
Contract Awards
227
Transactions
22
Price Lists
Opportunity Stack
1
Federal Agency
Veterans Integrated Service Network 12
Awardee
Emergent Devices, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pharmaceuticals and Drugs
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Pharmaceuticals and Drugs (FSS-61-IB)
Master GSA Schedule
V797D70052
Federal Supply Schedule
-
Blanket Purchase Agreements
227
Federal Contract Awards
Description
Update #1
65 I B, DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCT FSS CONTRACT AWARD
Posted 1/17/17, 12:00 AM
Mod #
Description
Reason For Modification
Federal Obligation
(Click to sort descending)
Date
(Click to sort ascending)
P00022
FSS
Supplemental Agreement for work within scope
$0
7/13/23
P00021
FSS
Supplemental Agreement for work within scope
$0
12/28/22
P00020
CONTRACT EXTENSION MODIFICATION.
Supplemental Agreement for work within scope
$0
12/27/22
P00019
PUBLIC LAW 2023
Supplemental Agreement for work within scope
$0
12/6/22
P00018
SIGNATORY AUTHORITY FORM CHANGES.
Supplemental Agreement for work within scope
$0
10/7/22
Name
Description
Awardee
Potential Value
(Click to sort descending)
Award Date
(Click to sort descending)
Last Date To Order
(Click to sort descending)
Updated At
(Click to sort descending)
V797D70052-HHSI246201800069B
BPA FOR NALOXONE NASAL SPRAY
Emergent Devices, Inc.
$600.0k
3/15/18
3/19/19
3/15/18
V797D70052-HHSI246201700099B
BPA FOR NALOXONE NASAL SPRAY SUPPLIES FOR NSSC CUSTOMERS
Emergent Devices, Inc.
$160.0k
3/10/17
3/9/18
3/10/17
V797D70052-75H71119A00116
NARCAN NASAL SPRAY FOR NSSC WAREHOUSE CUSTOMERS.
Emergent Devices, Inc.
$300.0k
5/8/19
12/31/19
8/7/19
Name
Description
Awardee
Potential Value
(Click to sort descending)
Award Date
(Click to sort descending)
Completion Date
(Click to sort descending)
Updated At
(Click to sort descending)
Delivery Order V797D70052-HSBP1017F00335
NOSE SPRAY
Emergent Devices, Inc.
$54.3k
9/18/17
10/18/17
9/18/17
BPA Call HHSI246201800069B-75H71119F27003
ADAPT PHARMA INC HHSI246201800069B REQUEST FUNDS FOR STORE STOCK ITEMS FOR NSSC WAREHOUSE CUSTOMERS
Emergent Devices, Inc.
$35.0k
11/14/18
3/19/19
11/14/18
Delivery Order V797D70052-15B10918FTB110597
DRUGS/MEDICATIONS - NON-CONTROLLED SUBSTANCE NARCAN (NALOXONE) SPRAY FOR BOP EMERGENCY PROCEDURES
Emergent Devices, Inc.
$824
8/13/18
8/31/18
8/13/18
Delivery Order V797D70052-36C77021N0150
Emergent Devices Inc. was awarded a $678,720 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 (VA VHA VISN 12). The delivery order is for the refill of pharmaceutical items to meet the clinical and operational pharmacy services needs of VA VHA VISN 12. Performance will take place in Wayne, Pennsylvania over a one week period from April 8, 2021 through April 15, 2021. Pricing is firm fixed price. No subcontractors or set aside designations were identified. The delivery order was issued under the VA's master agreement to procure prescription drugs and support its mission to provide quality healthcare to America's veterans.
Emergent Devices, Inc.
$678.7k
4/8/21
4/15/21
4/8/21
Delivery Order V797D70052-15B31720FVB130005
PHARMACEUTICAL SUPPLIES
Emergent Devices, Inc.
$5.9k
10/25/19
10/25/19
10/25/19
Name
Description
Solicitation Number
Federal Agency
Type
Posted Date
(Click to sort descending)
Roxane Laboratories, Inc. 900 Ridgebury Road Ridgefield, CT 06877
The Department of Veterans Affairs National Acquisition Center awarded Roxane Laboratories, Inc. a multiple award schedule contract to supply drugs, pharmaceuticals, and hematology products under Federal Supply Schedule 65IB. The base period of performance is from August 12, 2016 to August 11, 2021, with subsequent option periods potentially extending the contract through August 11, 2026. This indefinite delivery, indefinite quantity contract establishes firm fixed pricing for pharmaceutical supplies that can be ordered by the VA and other federal agencies on an as-needed basis to support veterans' healthcare programs.
65IB
Department of Veterans Affairs National Acquisition Center
Award Notice 1/1
8/12/16, 2:39 PM